The IASLC will host a #TTLC21 highlights meeting for delegates in Europe and Asia on March 3-4
PUBLISHED: 2021-03-02   2025 total views, 23 today



Register here: https://ttlc2021.iaslc.org/highlights-europe-asia/

Asian Highlights

3 MARCH 2021

13:30 – 14:40 CET Targeted Therapies – EGFR/ ALK/ MET

• Welcome Introduction                                Tetsuya Mitsudomi, Japan

• EGFR Exon 20 Insertions: Novel TKIs, Amivantamab and Other Treatment Options Zosia Piotrowska, USA

• Persister Biology                                          Christine Lovly, USA

• New Studies of Approved Agents: Crizotinib, Ceritinib, Alectinib, Lorlatinib, Ensartinib - New Data and Resistance Mechanisms      Ignatius (Sai-Hong) Ou, USA

• MET                                                                  Rebecca Heist, USA

• Live Panel Discussion

 14:40 – 15:40 CET Targeted Therapies – RET/HER2/NRG/NTRK/KRAS

• RET Fusion-Positive Lung Cancers                                    Alex Drilon, USA

• HER2, NTRK, NRG1 "Too Many Topics for a Pun"         Stephen Liu, USA

• Sotorasib for KRAS G12C                                                          Bob Li, USA

• KRAS G12C Inhibitor Combinations                              Gregory Riely, USA

• Live Panel Discussion

4 MARCH 2021

13:30 – 14:40 CET The Future of Immunotherapy

• Immunotherapy Combos: LAG-3, TIM-3, TIGIT, OX-40       Rachel Sanborn, USA

• Immunotherapy Combinations CTLA-4, 41BB, ICOS Jarushka Naidoo, Ireland

• Personalized Cancer Vaccines                                                        Justin Gainor, USA

• Aiming the Immune System at Mutation-Driven Tumors Charu Aggarwal, USA

• Live Panel Discussion

14:40 – 15:40 CET SCLC/Perioperative/Antibody Drug Conjugates

• New Therapeutic Targets for SCLC                                           Charles Rudin, USA

• Adjuvant Immunotherapy & Chemo-Immunotherapy: Phase 2 Results & Ongoing

Trials                                                                                              Patrick Forde, USA

• Neoadjuvant & Adjuvant TKI Trials                                            Jamie Chaft, USA

• Antibody Drug Conjugates for HER2 & HER3                              Pasi Janne, USA

• Live Panel Discussion


Copyright © 1998 - 2021 Chinese Society of Clinical Oncology(CSCO). All Rights Reserved

京公网安备 11010502031031号

Contact Us

EMAIL:office@csco.org.cn

international@csco.org.cn

Phone:86(10)67726451 (Beijing)

86(25)84547290 (Nanjing)